Your browser doesn't support javascript.
loading
Clinical outcomes of advanced stage cancer patients treated with sequential immunotherapy in phase 1 clinical trials.
Martini, Dylan J; Liu, Yuan; Shabto, Julie M; Lewis, Colleen; Kline, Meredith R; Collins, Hannah; Akce, Mehmet; Kissick, Haydn T; Carthon, Bradley C; Shaib, Walid L; Alese, Olatunji B; Pillai, Rathi N; Steuer, Conor E; Wu, Christina S; Lawson, David H; Kudchadkar, Ragini R; Master, Viraj A; El-Rayes, Bassel F; Ramalingam, Suresh S; Owonikoko, Taofeek K; Harvey, R Donald; Bilen, Mehmet Asim.
Afiliação
  • Martini DJ; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.
  • Liu Y; Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Shabto JM; Departments of Biostatistics and Bioinformatics, Emory University, Atlanta, GA, USA.
  • Lewis C; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.
  • Kline MR; Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Collins H; Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Akce M; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.
  • Kissick HT; Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Carthon BC; Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Shaib WL; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.
  • Alese OB; Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Pillai RN; Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Steuer CE; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA.
  • Wu CS; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.
  • Lawson DH; Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Kudchadkar RR; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.
  • Master VA; Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • El-Rayes BF; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.
  • Ramalingam SS; Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Owonikoko TK; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.
  • Harvey RD; Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Bilen MA; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.
Invest New Drugs ; 37(6): 1198-1206, 2019 12.
Article em En | MEDLINE | ID: mdl-30725388
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Interferon gama / Interleucina-2 / Antineoplásicos Imunológicos / Imunoterapia / Neoplasias Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Invest New Drugs Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Interferon gama / Interleucina-2 / Antineoplásicos Imunológicos / Imunoterapia / Neoplasias Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Invest New Drugs Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos